Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2026-04-21 @ 10:45 PM
Study NCT ID:
NCT00129168
Status:
COMPLETED
Last Update Posted:
2008-04-01
First Post:
2005-08-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)
Sponsor:
Kanisa Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KAN-979-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None